Open AccessA phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease
Author(s) -
M. V. RAGNI,
R. C. JANKOWITZ,
H. L. CHAPMAN,
E. P. MERRICKS,
M. T. KLOOS,
A. M. DILLOW,
T. C. NICHOLS
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/eyh2-c733
Subject(s) - open label , recombinant dna , von willebrand disease , medicine , disease , von willebrand factor , immunology , clinical trial , chemistry , biochemistry , platelet , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom